Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.

By Xiaolei Zhu, Shenhong Wu, W. Dahut, C. Parikh. American Journal of Kidney Diseases, 2007

647 citations recorded by the source corpus.